Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]

View source ↗

Summary

This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recruiting, sponsored by C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Antiphospholipid Syndrome
• Inflammatory Myopathy
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• YTS109 cell injection (YTS109 cell therapy)

Snippet

Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Conditions: Systemic Lupus Erythematosus, Systemic Sclerosis | NA | Status: RECRUITING